account_balance
Investment manager · 13F filer · SEC CIK 1697013
Eversept Partners, LP
Reported value$1.83Bas of Jun 30, 2026
Positions115 32 new, 21 sold out
Top 10 weight46.6%UTHR alone is 8%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
UTHRUnited Therapeutics Corp
8.5%Added +9%
ABVXAbivax SA
6.6%Trimmed −2%
EHCEncompass Health Corp
5.7%Added +429%
ENSGEnsign Group Inc
5.3%Added +3979%
VERAVera Therapeutics Inc
5.2%
CLDXCelldex Therapeutics Inc New
3.6%
SNDXSyndax Pharmaceuticals Inc
3.3%Trimmed −3%
BKDBrookdale Sr Living Inc
3.0%Trimmed −5%
IONSIonis Pharmaceuticals Inc
2.9%Added +5%
NTRANatera Inc
2.6%Trimmed −54%
TVTXTravere Therapeutics Inc
2.5%Added +47%
CTRECaretrust REIT Inc
2.4%New
UTHRUnited Therapeutics Corp
8.5%Added +9%
ABVXAbivax SA
6.6%Trimmed −2%
EHCEncompass Health Corp
5.7%Added +429%
ENSGEnsign Group Inc
5.3%Added +3979%
VERAVera Therapeutics Inc
5.2%
CLDX3.6%SNDX3.3%BKD3.0%IONS2.9%NTRA2.6%TVTX2.5%CTRE2.4%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
UTHR United Therapeutics Corp 8.5% Added +9%ABVX Abivax SA 6.6% Trimmed −2%EHC Encompass Health Corp 5.7% Added +429%ENSG Ensign Group Inc 5.3% Added +3979%VERA Vera Therapeutics Inc 5.2% HeldCLDX Celldex Therapeutics Inc New 3.6% HeldSNDX Syndax Pharmaceuticals Inc 3.3% Trimmed −3%BKD Brookdale Sr Living Inc 3.0% Trimmed −5%IONS Ionis Pharmaceuticals Inc 2.9% Added +5%NTRA Natera Inc 2.6% Trimmed −54%TVTX Travere Therapeutics Inc 2.5% Added +47%CTRE Caretrust REIT Inc 2.4% New
What changed